FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sam Schulman

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Administration, Oral

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Sam Schulman; A C Spyropoulos; S Divakara Menon; J S Healey; J Schoenberg; John W Eikelboom
Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion.
Sam Schulman
Tossing a coin or using common sense.
Sam Schulman; M Crowther; A Holbrook
The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sam Schulman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sam Schulman; A C Spyropoulos; S Divakara Menon; J S Healey; J Schoenberg; John W Eikelboom
Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion.
Thrombosis research 2013;131(4):300-3.
2013: Sam Schulman
Tossing a coin or using common sense.
Journal of thrombosis and haemostasis : JTH 2013;11(3):432-4.
2013: Sam Schulman; M Crowther; A Holbrook
The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal.
Journal of thrombosis and haemostasis : JTH 2013;11(3):566-7.
2013: P Y H Wong; S Woodworth; Sam Schulman; A Holbrook
Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis.
Journal of thrombosis and haemostasis : JTH 2013;11(3):491-502.
2013: Sam Schulman; David Baanstra; Henry Eriksson; Jeffrey Friedman; Samuel Z Goldhaber; Ajay K Kakkar; Clive Kearon; Anne Mathilde Kvamme; Patrick Mismetti; Sebastian Schellong
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.
The New England journal of medicine 2013;368(8):709-18.
2013: Maria Magnusson; Pia Petrini; Sam Schulman; Jan Svensson; Björn Fischler; Antal Németh
Bile acids and coagulation factors: paradoxical association in children with chronic liver disease.
European journal of gastroenterology & hepatology 2013;25(2):152-8.
2013: Sam Schulman
New anticoagulants in atrial fibrillation management.
Thrombosis research 2013;131 Suppl 1():S63-6.
2012: Sigurdur Y Kristinsson; Ruth M Pfeiffer; Sam Schulman; Magnus Björkholm; Ola Landgren
Thrombosis is associated with inferior survival in multiple myeloma.
Haematologica 2012;97(10):1603-7.
2012: Sam Schulman
Advances in the management of venous thromboembolism.
Best practice & research. Clinical haematology 2012;25(3):361-77.
2012: James D Douketis; Miriam Dwyer; Paul R Eisenberg; Shannon M Bates; Susan M Begelman; Philip C Comp; Mark A Crowther; Louis Desjardins; Jeffrey S Ginsberg; Susan Haley; Jim Julian; Scott S Kaatz; Jeannine Kassis; Clive Kearon; Mark Levine; Timothy A Morris; Sam Schulman; Richard Smart; Raymond Taillefer; Wendy Tsui; Richard H White; Mike Gerometta
Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study.
Thrombosis research 2012;130(3):381-9.
2012: Sam Schulman
Treatment of venous thromboembolism with dabigatran.
Current opinion in pulmonary medicine 2012;18(5):410-5.
2012: A C Spyropoulos; J D Douketis; G Gerotziafas; Scott S Kaatz; T L Ortel; Sam Schulman
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy.
Journal of thrombosis and haemostasis : JTH 2012;10(4):692-4.
2012: Sam Schulman; Mark A Crowther
How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch.
Blood 2012;119(13):3016-23.
2012: Lori-Ann Linkins; Lisa K Moores; Sam Schulman; Robert Bona; Mark Crowther; Antonio L Dans; Bruce L Davidson
Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest 2012;141(2 Suppl):e495S-530S.
2012: Anne Holbrook; Michael J Kovacs; Sam Schulman; Peter J Svensson; Per Olav Vandvik; David L Veenstra; Daniel M Witt; Mark Crowther; Jason Fish; Gordon H Guyatt
Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest 2012;141(2 Suppl):e152S-84S.
2012: Gordon H Guyatt; Jack Hirsh; Sandra Zelman Lewis; Marian S McDonagh; Susan L Norris; Sam Schulman; Holger J Schünemann; Per Olav Vandvik; Elie A Akl; Deborah J Cook; Mark Crowther; Mark H Eckman; John W Eikelboom; David D Gutterman
Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest 2012;141(2 Suppl):53S-70S.
2012: Sam Schulman; Ammar Majeed
The oral thrombin inhibitor dabigatran: strengths and weaknesses.
Seminars in thrombosis and hemostasis 2012;38(1):7-15.
2012: Sam Schulman
Pharmacologic tools to reduce bleeding in surgery.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2012;2012():517-21.
2011: Theodore E Warkentin; Mohan Pai; Sam Schulman; J I Sheppard; A C Spyropoulos; John W Eikelboom
Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.
Journal of thrombosis and haemostasis : JTH 2011;9(12):2389-96.
2011: Sam Schulman; Clare Stewart; Jim A Julian; Sameer Parpia; Lisa Rudd-Scott; Mark Levine
Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
Annals of internal medicine 2011;155(10):653-9, W201-3.
2011: Sam Schulman; Ammar Majeed
A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(6):449-63.
2011: Sigurdur Yngvi Kristinsson; Magnus Björkholm; Sam Schulman; Ola Landgren
Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance.
Seminars in hematology 2011;48(1):46-54.
2010: Menno V Huisman; Daniel J Quinlan; Ola E Dahl; Sam Schulman
Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
Circulation. Cardiovascular quality and outcomes 2010;3(6):652-60.
2010: Sam Schulman; David R Anderson; T J Bungard; T Jaeger; Susan R Kahn; P Wells; S J Wilson
Direct and indirect costs of management of long-term warfarin therapy in Canada.
Journal of thrombosis and haemostasis : JTH 2010;8(10):2192-200.
2010: Sam Schulman
New aspects on treatment modalities for thromboembolic episodes.
Journal of internal medicine 2010;268(2):109-19.
2010: Mark A Crowther; David Garcia; Walter Ageno; Luqi Wang; Dan M Witt; Nathan P Clark; Mark D Blostein; Susan R Kahn; Sam Schulman; Michael Kovacs; Marc A Rodger; Philip Wells; David Anderson; Jeffrey Ginsberg; Rita Selby; Sergio Siragusa; Mauro Silingardi; MaryBeth B Dowd; Clive Kearon
Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study.
Thrombosis and haemostasis 2010;104(1):118-21.
2010: Sam Schulman; A Melinyshyn; D Ennis; L Rudd-Scott
Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range.
Thrombosis research 2010;125(5):393-7.
2010: Sam Schulman; Frederick A Spencer
Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding.
Journal of thrombosis and haemostasis : JTH 2010;8(4):641-50.
2010: Sam Schulman; U Angerås; D Bergqvist; B Eriksson; Michael R Lassen; W Fisher
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.
Journal of thrombosis and haemostasis : JTH 2010;8(1):202-4.
2010: Y-K Kim; R Nieuwlaat; S J Connolly; Sam Schulman; K Meijer; N Raju; Scott S Kaatz; John W Eikelboom
Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study.
Journal of thrombosis and haemostasis : JTH 2010;8(1):101-6.
2009: Sam Schulman; Clive Kearon; Ajay K Kakkar; Patrick Mismetti; Sebastian Schellong; Henry Eriksson; David Baanstra; Janet Schnee; Samuel Z Goldhaber
Dabigatran versus warfarin in the treatment of acute venous thromboembolism.
The New England journal of medicine 2009;361(24):2342-52.
2009: Sam Schulman
Rivaroxaban in orthopedic surgery--a change of paradigm?
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(6):613-20.
2009: Sam Schulman; Paul A Reilly
Dabigatran etexilate: future directions in anticoagulant treatment.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15 Suppl 1():32S-41S.
2009: Sam Schulman
Getting intimate with the venous thrombus.
Journal of thrombosis and haemostasis : JTH 2009;7(8):1266-7.
2009: Yang-Ki Kim; Sam Schulman
Cervical artery dissection: pathology, epidemiology and management.
Thrombosis research 2009;123(6):810-21.
2009: Mark A Crowther; Walter Ageno; David Garcia; Luqi Wang; Dan M Witt; Nathan P Clark; Mark D Blostein; Susan R Kahn; Sara Vesely; Sam Schulman; Michael J Kovacs; Marc A Rodger; Philip Wells; David Anderson; Jeffery Ginsberg; Rita Selby; Sergio Siragusa; Mauro Silingardi; Mary Beth Dowd; Clive Kearon
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
Annals of internal medicine 2009;150(5):293-300.
2009: Marlene Robinson; Jeff S Healey; John Eikelboom; Sam Schulman; Carlos A Morillo; Girish M Nair; Adrian Baranchuk; Sebastian Ribas; Geoff Evans; Stuart J Connolly; AG Turpie
Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators.
Pacing and clinical electrophysiology : PACE 2009;32(3):378-82.
2009: Sam Schulman; A Eelde; Margareta Blombäck; J Stenflo
The plasma concentration of activated protein C appears normal in patients with haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(2):566-70.
2008: E Jamula; James D Douketis; Sam Schulman
Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.
Journal of thrombosis and haemostasis : JTH 2008;6(10):1615-21.
2008: Sam Schulman; Rajae Elbazi; Michelle Zondag; Martin O'Donnell
Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study.
Thrombosis journal 2008;6():15.
2008: Sam Schulman
Extension of anticoagulation after venous thromboembolism - risk factors influencing the decision.
Hämostaseologie 2008;28(3):110-9.
2007: Anna Agren; Björn Wiman; Sam Schulman
Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(7):657-60.
2007: Anna Agren; T Kolmert; Björn Wiman; Sam Schulman
Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate.
Thrombosis research 2007;119(6):715-21.
2006: Sam Schulman; P Lindmarker; Margareta Holmström; G Lärfars; A Carlsson; P Nicol; E Svensson; B Ljungberg; S Viering; S Nordlander; B Leijd; K Jahed; Martin Hjorth; Olle Linder; M Beckman
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months.
Journal of thrombosis and haemostasis : JTH 2006;4(4):734-42.
2006: Anna Agren; Björn Wiman; V Stiller; P Lindmarker; Margareta Sten-Linder; A Carlsson; Margareta Holmström; J Odeberg; Sam Schulman
Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis.
Journal of thrombosis and haemostasis : JTH 2006;4(1):201-8.
2004: Sam Schulman; J Loogna; R Wallensten
Minimizing factor requirements for surgery without increased risk.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10 Suppl 4():35-40.
2004: K Steen Carlsson; S Höjgård; A Lindgren; Stefan Lethagen; Sam Schulman; A Glomstein; Lilian Tengborn; Erik Berntorp; B Lindgren
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10(5):515-26.
2003: K Steen Carlsson; S Höjgård; A Glomstein; Stefan Lethagen; Sam Schulman; Lilian Tengborn; A Lindgren; Erik Berntorp; B Lindgren
On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9(5):555-66.
2002: Sam Schulman; Margareta Hellgren-Wångdahl
Pregnancy, heparin and osteoporosis.
Thrombosis and haemostasis 2002;87(2):180-1.
2001: Sam Schulman; H Johnsson; Erik Berntorp; Lennart Stigendal
[Prothromplex in stead of Beriplex P/N as acute antidote against warfarin].
Läkartidningen 2001;98(36):3807.
2000: Sam Schulman
[Venous thromboembolism, warfarin and cancer--a well-known connection].
Läkartidningen 2000;97(41):4554.
2000: Sam Schulman; P Lindmarker
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.
The New England journal of medicine 2000;342(26):1953-8.
1999: Jan Astermark; P Petrini; Lilian Tengborn; Sam Schulman; Rolf Ljung; Erik Berntorp
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized.
British journal of haematology 1999;105(4):1109-13.
1999: Sam Schulman
Haemostatic and replacement therapy in von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 1999;5 Suppl 2():57-9.
1999: Erik Berntorp; J Ingerslev; Sam Schulman
Von Willebrand disease: an update in the Aland islands.
Haemophilia : the official journal of the World Federation of Hemophilia 1999;5 Suppl 2():1-6.
1999: P Lindmarker; Sam Schulman; Margareta Sten-Linder; Björn Wiman; Nils Egberg; H Johnsson
The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
Thrombosis and haemostasis 1999;81(5):684-9.
1999: Erik Berntorp; Stefan Lethagen; Rolf Ljung; H Johnsson; P Petrini; Sam Schulman; Lilian Tengborn; B Rehnby; E Sarman; B Asberg
[Centralized care is the basis of care programs for hemophilia patients].
Läkartidningen 1999;96(15):1849-52.
1998: Jan Astermark; T Löfqvist; Sam Schulman; Lennart Stigendal; Stefan Lethagen; IM Nilsson; Erik Berntorp
Major surgery seems not to influence HIV disease progression in haemophilia patients.
British journal of haematology 1998;103(1):10-4.
1998: Sam Schulman; Roseline d'Oiron; Uri martinowitz; John Pasi; Marie-Elisabeth Briquel; Eveline P Mauser-Bunschoten; Massimo Morfini; B Ritchie; Jenny Goudemand; J Lloyd; J McPherson; Claude Négrier; Kathelijne Peerlinck; P Petrini; J Tusell
Experiences with continuous infusion of recombinant activated factor VII.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9 Suppl 1():S97-101.
1998: Sam Schulman; M Von Sydow; P Petrini; P Fahlstadius
Hepatitis C virus-infected, HCV-RNA-negative patients with bleeding disorders--relationship to age, HIV and treatment.
Scandinavian journal of infectious diseases 1998;30(5):455-8.
1997: Sam Schulman
Optimal duration of oral anticoagulant therapy in venous thromboembolism.
Thrombosis and haemostasis 1997;78(1):693-8.
1997: Sam Schulman; S Granqvist; Margareta Holmström; A Carlsson; P Lindmarker; P Nicol; S G Eklund; S Nordlander; G Lärfars; B Leijd; Olle Linder; E Loogna
The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
The New England journal of medicine 1997;336(6):393-8.
1996: Sam Schulman
Anticoagulation in venous thrombosis.
Journal of the Royal Society of Medicine 1996;89(11):624-30.
1996: Sam Schulman; Björn Wiman
The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group.
Thrombosis and haemostasis 1996;75(4):607-11.
1995: Sam Schulman; A S Rhedin; P Lindmarker; A Carlsson; G Lärfars; P Nicol; E Loogna; E Svensson; B Ljungberg; H Walter
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.
The New England journal of medicine 1995;332(25):1661-5.
1995: Sam Schulman; P Lindmarker; H Johnsson
Influence of changes in lifestyle on fibrinolytic parameters and recurrence rate in patients with venous thromboembolism.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6(4):311-6.
1992: Lilian Tengborn; Lennart Stigendal; Erik Berntorp; Stefan Lethagen; H Johnsson; Sam Schulman
[New preparations for coagulation disorders].
Läkartidningen 1992;89(28-29):2430.
1992: Sam Schulman
A therapeutic alternative for haemophiliacs with inhibitors.
Acta paediatrica (Oslo, Norway : 1992) 1992;81(6-7):564-5.
1991: Sam Schulman; H Johnsson; P Lindmarker
Thrombotic complications after substitution with a FVII concentrate.
Thrombosis and haemostasis 1991;66(5):619.
1991: Sam Schulman
Effects of factor VIII concentrates on the immune system in hemophilic patients.
Annals of hematology 1991;63(3):145-51.
1991: Sam Schulman
DDAVP--the multipotent drug in patients with coagulopathies.
Transfusion medicine reviews 1991;5(2):132-44.
1991: Sam Schulman; H Johnsson
Heparin, DDAVP and the bleeding time.
Thrombosis and haemostasis 1991;65(3):242-4.
1989: Sam Schulman; K Henriksson
Interaction of ibuprofen and warfarin on primary haemostasis.
British journal of rheumatology 1989;28(1):46-9.
1989: Sam Schulman; H Johnsson; Björn Wiman
Acute effects with reference to thrombogenicity and liver toxicity after injection of different coagulation factor concentrates.
Haemostasis 1989;19(3):152-9.
1988: Sam Schulman; L Stigendal; J H Jansson; J Brohult
Haemorrhagic and thromboembolic complications versus intensity of treatment of venous thromboembolism with oral anticoagulants.
Acta medica Scandinavica 1988;224(5):425-30.
1987: Sam Schulman; Lilian Tengborn; Lennart Stigendal
[Hereditary thrombogenic defects in the national family registry].
Läkartidningen 1987;84(15):1251-3.
1986: Sam Schulman; S Granqvist; A Juhlin-Dannfelt; D Lockner
Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinase.
Acta medica Scandinavica 1986;219(4):349-57.
1985: Sam Schulman; S Granqvist; B Wiman; D Lockner
Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis.
Thrombosis research 1985;39(5):607-12.
1984: Sam Schulman; D Lockner; S Granqvist; G Bratt; C Paul; Dag Nyman
A comparative randomized trial of low-dose versus high-dose streptokinase in deep vein thrombosis of the thigh.
Thrombosis and haemostasis 1984;51(2):261-5.